Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation

Nils Milman, Claus B Andersen, Annette Hansen, Thomas van Overeem Hansen, Finn C Nielsen, Hans Fledelius, Peter Ahrens, Ole Haagen Nielsen

71 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation'. Together they form a unique fingerprint.

Medicine & Life Sciences